Response to letter entitled: Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials

被引：2
|
作者：
Agostinetto, Elisa [1 ,2 ,3 ,7 ]
Ceppi, Marcello [4 ]
Bruzzone, Marco [4 ]
Lambertini, Matteo [5 ,6 ]
de Azambuja, Evandro [1 ,2 ]
机构：
[1] Inst Jules Bordet, Acad Trials Promoting Team, Blvd Waterloo 121, B-1000 Brussels, Belgium
[2] Univ Libre Bruxelles ULB, Brussels, Belgium
[3] Humanitas Clin & Res Ctr IRCCS, Humanitas Canc Ctr, Med Oncol & Hematol Unit, Milan, Italy
[4] IRCCS Osped Policlin San Martino, Unit Clin Epidemiol, Genoa, Italy
[5] Univ Genoa, Sch Med, Dept Internal Med & Med Specialties DiMI, Genoa, Italy
[6] IRCCS Osped Policlin San Martino, Dept Med Oncol, UO Clin Oncol Med, Genoa, Italy
[7] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Pieve Emanuele Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 155卷
关键词：
D O I：
10.1016/j.ejca.2021.06.042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：303 / 306
页数：4
相关论文
共 50 条
  • [1] Re: Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials An enigmatic discordance resolved
    Salem, Joe-Elie
    Ederhy, Stephane
    Dechartres, Agnes
    EUROPEAN JOURNAL OF CANCER, 2021, 155 : 299 - 302
  • [2] Original Research Cardiotoxicity of immune checkpoint inhibitors: A systematic review and meta-analysis of randomised clinical trials
    Agostinetto, Elisa
    Eiger, Daniel
    Lambertini, Matteo
    Ceppi, Marcello
    Bruzzone, Marco
    Ponde, Noam
    Plummer, Chris
    Awada, Ahmad H.
    Santoro, Armando
    Piccart-Gebhart, Martine
    de Azambuja, Evandro
    EUROPEAN JOURNAL OF CANCER, 2021, 148 : 76 - 91
  • [3] Cardiotoxicity of immune checkpoint inhibitors: A meta-analysis of randomized clinical trials
    Agostinetto, E.
    Eiger, D.
    Lambertini, M.
    Ceppi, M.
    Bruzzone, M.
    Ponde, N. F.
    Plummer, C.
    Awada, A. H.
    Piccart, M.
    de Azambuja, E.
    ANNALS OF ONCOLOGY, 2020, 31 : S1432 - S1432
  • [4] Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis
    Shen, Xin
    Yang, Jun
    Qian, Geng
    Sheng, Mingyu
    Wang, Yu
    Li, Guohui
    Yan, Jiaqing
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [5] Rechallenge of immune checkpoint inhibitors: A systematic review and meta-analysis
    Inno, Alessandro
    Roviello, Giandomenico
    Ghidini, Antonio
    Luciani, Andrea
    Catalano, Martina
    Gori, Stefania
    Petrelli, Fausto
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2021, 165
  • [6] Risk Factors for Cardiotoxicity in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review With Meta-Analysis
    Huang, Chin-Hsuan
    Abdul-Lattif, Eahab
    Azmat, Muneeba
    Chang, Yu
    Lin, Yu Shiuan
    Md, Michele Nanna
    Chi, Kuan Yu
    CIRCULATION, 2022, 146
  • [7] Immune Checkpoint Inhibitor-Induced Cardiotoxicity: A Systematic Review and Meta-Analysis
    Nielsen, Dorte Lisbet
    Juhl, Carsten Bogh
    Nielsen, Ole Haagen
    Chen, Inna Markovna
    Herrmann, Joerg
    JAMA ONCOLOGY, 2024,
  • [8] Re: Typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials
    Arya, Subhash C.
    Agarwal, Nirmata
    VACCINE, 2008, 26 (03) : 291 - 291
  • [9] Systematic review: cardiotoxicity of immune checkpoint inhibitors
    Reactions Weekly, 2021, 1849 (1) : 11 - 11
  • [10] Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis
    Liu, Maobai
    Cheng, Xitong
    Ni, Ruping
    Zheng, Bin
    Huang, Shunmin
    Yang, Jing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345